Bio Protocol vs Orbiter Finance — how do they compare? Bio Protocol trades at Rp514.08 (market cap Rp1,16T, Rp252,63M 24h volume), while Orbiter Finance trades at Rp6.17 (market cap Rp33,75M, Rp22,97M 24h volume). The key difference: Bio Protocol is far larger — about 34370.4× Orbiter Finance's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 5,5B / 10B OBT (56%) for Orbiter Finance. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Orbiter Finance for 10 Days on average.
| BIO | OBT | |
|---|---|---|
Market Cap | Rp1,16T | Rp33,75M |
Volume (24h) | Rp252,63M | Rp22,97M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 5,5B / 10B OBT (56%) |
Typical Hold Time | 16 Days | 10 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Orbiter Finance is an interoperability blockchain infrastructure based on zero-knowledge technology (ZK-tech). It aims to enhance the security of blockchain interactions, ensure seamless interoperability, and reduce liquidity fragmentation. Orbiter achieves this through innovative solutions, including a universal cross-chain protocol and Omni Account Abstraction. Its goal is to redefine the Web3 experience in the multichain era.
Read more on OBT →